BeStock  

Stevanato Group STVN

$15.65 −$0.28 (-1.76%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.65 0.00%
Open$15.90
Prev close$15.93
Day range$15.35 – $16.15
Volume752.3K
Market cap$4.27B
P/E (TTM)28.0
Dividend yield0.39%

Earnings

Average move on report day±9.2%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+18.8%
Worst reaction-28.6%

Stock move on the day after each report

-8.2%2023/Q4-21.6%2024/Q1+5.7%2024/Q2+16.1%2024/Q3+8.6%2024/Q4+3.1%2025/Q1-9.7%2025/Q2-2.4%2025/Q3+18.8%2025/Q4-5.1%2026/Q1-4.6%2026/Q2-28.6%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q33 Nov 2026Pre Market±18.0%-28.57%Bigger than priced
2026/Q24 Aug 2026Pre Market±9.5%-4.57%Within range
2026/Q17 May 2026Pre Market±21.0%-5.11%Within range
2025/Q44 Mar 2026Pre Market±25.3%+18.81%Within range
2025/Q36 Nov 2025Pre Market±20.4%-2.36%Within range
2025/Q25 Aug 2025Pre Market±12.2%-9.73%Within range
2025/Q18 May 2025Pre Market±22.3%+3.12%Within range
2024/Q46 Mar 2025Pre Market±18.3%+8.60%Within range
2024/Q35 Nov 2024Pre Market±14.6%+16.10%Bigger than priced
2024/Q26 Aug 2024Pre Market±29.1%+5.75%Within range
2024/Q19 May 2024Pre Market±22.1%-21.59%Within range
2023/Q47 Mar 2024Pre Market±17.3%-8.22%Within range
2023/Q331 Oct 2023Pre Market±13.9%+2.19%Within range
2023/Q228 Jul 2023Pre Market±11.2%+2.33%Within range
2023/Q14 May 2023Pre Market–-3.35%–
2022/Q42 Mar 2023Pre Market±8.3%+6.18%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Biopharmaceutical and Diagnostic Solutions€294.30M 85.7%
  • Engineering€49.21M 14.3%

Latest reported quarter: Q3, ended Sep 2026 · reported in EUR

Revenue€326.06M+7.6% YoY
Operating profit€60.33M+14.4% YoY
Net profit€41.84M+16.0% YoY
Diluted EPS€0.15+15.4% YoY
Free cash flow€21.38M+1,933.2% YoY
Operating cash flow€57.64M

Revenue, last 8 quarters

€330.6MDec '24€256.6MMar '25€280.0MJun '25€303.2MSep '25€346.5MDec '25€273.6MMar '26€302.0MJun '26€326.1MSep '26

Net profit, last 8 quarters

€48.3MDec '24€26.5MMar '25€29.7MJun '25€36.1MSep '25€47.6MDec '25€28.0MMar '26€23.0MJun '26€41.8MSep '26

Profitability & balance sheet

Gross margin29.2%
Operating margin17.7%
Net margin11.2%
Return on equity9.3%
Return on assets5.5%
Return on invested capital7.3%
Current ratio1.73
Liabilities / assets40.2%
Cash & investments€115.62M
Total debt€464.67M
Net cash (debt)-€349.05M

Discussion

No comments yet — be the first to weigh in on STVN.

Sign in to join the discussion.

Scroll to Top